Filter By “Clinical Trials”
Launching Datavant Trials for next-generation RWD connectivity
Over the last three years, the proliferation of real-world data at scale has dramatically changed how researchers are thinking about study design, operations, and execution – and the role digital patient data can play. We believe that over the next five years, tokenized clinical trials will be critical to reducing study costs and a force multiplier for accelerating therapeutic innovations for patients. Read this blog post to learn more about about vision and investment in trial tokenization.
How-to Guide: Readying Your Clinical Trial for Linkage with Real-World Data
When it comes to recruiting patients for clinical trials and collecting the necessary data to assess the impact and safety of novel therapies, trial sponsors and sites are facing greater challenges than ever before.
UCB Digital Health Roundtable: Capturing real-world data and evidence in clinical trials
For decades the best practices of clinical research involved rigidly designed, prospective randomized controlled trials (RCTs). While that remains the case in many scenarios, these kinds of trials collected data under ideal conditions and did not always reflect the routine clinical practice settings they are meant to inform. Over the last decade, as real-world data methodology advances and related regulatory guidance has matured it has allowed us to generate the evidence needed for strategy and decision making within development itself.
Trial Tokenization to Understand the Long Term Effectiveness of a New COVID-19 Vaccine
A biopharma company was conducting a Phase III study to assess the safety and effectiveness of a new COVID-19 vaccine. They needed to identify and connect to real-world data sources that would enable observation of infection rates and adverse events beyond the period of the trial.